Axcelis built its franchise on silicon carbide ion implant tools, but the SiC slowdown directly undermines that growth story. Chinese power device manufacturers are reducing tool orders as domestic alternatives improve. Mature node implant remains steady but provides less upside than the SiC bull case priced in. Margins compress as mix shifts away from high-end SiC.
Signals scoped to US · Company-specific tagging coming soon.